SCHEMBL22996015

SCHEMBL22996015

CC(NC(=O)C(C)(C)C)C(C)(C)C(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.35
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP3A4 P08684 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
POLB P06746 3/20 0.33
CNR2 P34972 1/20 0.33
MAPK1 P28482 1/20 0.33
TAS1R3 Q7RTX0 3/20 0.32
TAS1R1 Q7RTX1 3/20 0.32
TAS1R2 Q8TE23 3/20 0.32
GAA P10253 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
KDM4E B2RXH2 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
MAPT P10636 1/20 0.32
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16643942 0.82 CYP2C9 (0.45) NPSR1CYP2C9CYP2C19CYP3A4L3MBTL1
SCHEMBL16643945 0.82 CYP2C9 (0.45) NPSR1CYP2C9CYP2C19CYP3A4L3MBTL1
SCHEMBL16643953 0.82 CYP2C9 (0.45) NPSR1CYP2C9CYP2C19CYP3A4L3MBTL1
SCHEMBL21187752 0.76 NPSR1 (0.35) NPSR1CYP2C9CYP2C19CYP3A4L3MBTL1
SCHEMBL24852434 0.76 CYP2C9 (0.37) NPSR1CYP2C9CYP2C19CYP3A4L3MBTL1
SCHEMBL17721113 0.76 CYP2C9 (0.37) NPSR1CYP2C9CYP2C19CYP3A4L3MBTL1
SCHEMBL25576819 0.76 CYP2C9 (0.37) NPSR1CYP2C9CYP2C19CYP3A4L3MBTL1
SCHEMBL152945 0.74 SIGMAR1 (0.40) NPSR1CYP2C9CYP2C19L3MBTL1POLB
SCHEMBL20364044 0.74 NPSR1 (0.39) NPSR1CYP2C9CYP2C19CYP3A4L3MBTL1
SCHEMBL25967196 0.73 NPSR1 (0.36) NPSR1CYP2C9CYP2C19CYP3A4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11225551-B2 Amphiphilic block copolymer, preparation method thereof and nanomicelle drug-loading system SELECTION BIOSCIENCE LLC (CN) 2022-01-18 US disclosed
US-20210047467-A1 AMPHIPHILIC BLOCK COPOLYMER, PREPARATION METHOD THEREOF AND NANOMICELLE DRUG-LOADING SYSTEM SHANGHAI BEST-LINK BIOSCIENCE, LLC (CN) 2021-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210047467-A1 AMPHIPHILIC BLOCK COPOLYMER, PREPARATION METHOD THEREOF AND NANOMICELLE DRUG-LOADING SYSTEM TNF, IAPP, ABCE1 NPSR1 427/4885CYP2C9 243/4885CYP2C19 245/4885
US-11225551-B2 Amphiphilic block copolymer, preparation method thereof and nanomicelle drug-loading system TNF, IAPP, ABCE1 NPSR1 427/4885CYP2C9 243/4885CYP2C19 245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.